Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Early Palliative Integration, NSCLC

Jennifer Temel

MD

🏢Massachusetts General Hospital Cancer Center🌐USA

Director, Cancer Outcomes Research

38
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Jennifer Temel at Massachusetts General Hospital conducted the landmark randomized trial demonstrating that early integration of palliative care in metastatic NSCLC improved quality of life, reduced aggressive end-of-life care, and was associated with longer survival. Her research has transformed the practice of oncology by establishing concurrent early palliative care as standard for patients with advanced cancer.

Share:

🧪Research Fields 研究领域

early palliative care integration
NSCLC palliative trial
survival benefits palliative care
quality of life lung cancer
concurrent oncology palliative

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Jennifer Temel 的研究动态

Follow Jennifer Temel's research updates

留下邮箱,当我们发布与 Jennifer Temel(Massachusetts General Hospital Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment